Sun World Newsletter

Scientific Studies

Myo Inositol – Innovative therapeutic concept in the treatment of infertility associated with polycystic ovary syndrome

Myo Inositol – Innovative therapeutic concept in the treatment of infertility associated with polycystic ovary syndrome

31.01.2014

Insulin resistance is another common feature of PCOS in both overweight and lean women,8 and it is often treated with insulin sensitizers.  Over the last decade, myo-inositol, an isomerized and dephosphorylated precursor of glucose-6-phosphate, has been used more and more as a natural insulin sensitizer. The role of myo-inositol in the pathophysiology of PCOS has been the focus of recent studies. It has been suggested that insulin resistance in PCOS women can be attributed to a deficiency of myo-inositol’s intracellular metabolites. 

Treating women with myo-inositol has been shown to reduce androgen levels, help restore ovulatory function, lower blood pressure, and decrease triglyceride levels.Recent  studies confirms prior studies that have shown that myo-inositol  administration improves endocrine parameters and insulin sensitivity, more so in women with higher fasting insulin levels, defined by a fasting insulin level greater than 12 µU/mL. Weight loss and dietary interventions are also known to improve insulin sensitivity and hyperandrogenism and restore ovulation in women with PCOS. Myo-inositol is a safe and effective natural medicine for improving insulin resistance and it should be recommended in conjunction with other positive lifestyle modifications for the management of PCOS and insulin resistance.

Myo Sun contains 2 grams of myo-inositol per sachet and also brings the benefit of folic acid